Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Douglas D. Letson"'
Autor:
David W. Johnson, Enrico de Belen, Brent Box, Timothy Edward Kubal, Larry Weems, Douglas D. Letson, Catherine Czarnecki, John W. Peabody, Othman Ouenes, David Paculdo
Publikováno v:
The American Journal of Medicine. 132:e778-e785
Rising health care costs, physician shortages, and an aging patient population have increased the demand and utilization of advanced practice providers (APPs). Despite their expanding role in care delivery, little research has evaluated the care deli
Autor:
Jason M Burkett, Howard L. McLeod, Douglas D. Letson, Neil Thomas Mason, Julio M. Pow-Sang, John W. Peabody, Robert A. Gatenby, Jingsong Zhang, Timothy Edward Kubal, Ryan Nelson
Publikováno v:
Journal of Clinical Oncology. 37:e18343-e18343
e18343 Background: We recently completed a study showing that adaptive abiraterone therapy (AT) led to more than a doubling of the time to radiographic progression (TTP) compared to continuous therapy (CT) in patients with metastatic castration resis
Publikováno v:
ResearcherID
e17622 Background: Standardizing the care of cancer patients around best evidence has proven remarkably intransigent to traditional education efforts and incentives. The failure of these efforts is...
Autor:
Douglas D. Letson, Marife Bacate, Timothy Edward Kubal, Johnathan M. Lancaster, Alberto Chiappori, John W. Peabody, Lisa DeMaria
Publikováno v:
Journal of Clinical Oncology. 32:252-252
252 Background: Despite the growing call for use of guidelines in cancer care, adherence to clinical pathways and clinical care transformation is a challenge. Moffitt Cancer Center (MCC) has addressed this challenge, in multiple service lines, using
Autor:
Riti Shimkhada, Karen K. Fields, Charles F. Andrews, John W. Peabody, Diana Tamondong Lachica, Douglas D. Letson, Timothy Edward Kubal, John T. Hamm, Richard M. Levine
Publikováno v:
Journal of Clinical Oncology. 32:49-49
49 Background: Before entering into risk bearing contracts with payors, ACOs are challenged to find a basis for forming partnerships. Specialty ACO networks, in particular, must find ways to provide a common, high standard of care among a typically v
Publikováno v:
Journal of Clinical Oncology. 32:6637-6637
6637 Background: Clinical pathways are associated with improved outcomes and reduced health care costs. However, physician adherence to clinical pathways remains a challenge for cancer centers acro...
Autor:
Randy Heysec, Daniel J. Indelicato, Alberto Chiappori, Steven Finklestein, Anthony P. Conley, Shailaja Ks Raj, Dmitry I. Gabrilovich, Douglas D. Letson, Scott J. Antonia, Marilyn M. Bui, Ricardo Gonzales
Publikováno v:
Journal of Clinical Oncology. 32:10519-10519
10519 Background: Patients with high grade, large (
Autor:
John W. Peabody, Douglas D. Letson, Diane K. Hammon, Rachel V. Lee, Alan F. List, Karen K. Fields
Publikováno v:
Journal of Clinical Oncology. 31:255-255
255 Background: Determining value requires detailed measurement of clinical services and associated costs. In the health reform era value demonstration presents a challenge for both providers and payors: providers, unable to demonstrate value, will b
Autor:
Douglas D. Letson, Steven A. Enkemann, Marilyn M. Bui, Damon R. Reed, Gregory C. Bloom, Robert S. Lavey, Ricardo J. Gonzalez, Dale Han, Jonathan S. Zager, Anthony P. Conley, David Cheong, Hideko Yamauchi, Vernon K. Sondak, Gang Han
Publikováno v:
Journal of Clinical Oncology. 30:10048-10048
10048 Background: Liposarcoma (LPS) dedifferentiation signifies conversion to a clinically aggressive phenotype, but the biologic processes required for this change have not been determined. We describe differential gene expression patterns between w
Autor:
Ricardo J. Gonzalez, Douglas D. Letson, Shawn Tejiram, Nasreen A. Vohra, Christy Chai, Marilyn M. Bui, Eric M. Toloza, Jacques P. Fontaine, David Cheong, Jongphil Kim, Damon R. Reed, Anthony P. Conley
Publikováno v:
Journal of Clinical Oncology. 30:10070-10070
10070 Background: Pulmonary metastasectomy (PM) for sarcoma can result in significant long term survival in carefully selected patients (pts). We report our experience with pulmonary metastasectomy. Methods: After IRB approval, 120 pts who underwent